Event category: Concurrent Session

Events

September 05, 2025

2025-09-05

01:15 PM (EDT) - 02:00 PM (EDT)

Innovation Stage

Concurrent Session

Innovations in Antiarrhythmic Drug Therapy: Oxymoron or a Turning Point in the Field

Catheter ablation has become the dominant form of therapeutic intervention for cardiac arrhythmias. However, preclinical development of new antiarrhythmic drugs is very robust. These new molecular entities are not limited to antagonism of membrane active ion channels, but target additional mechanisms of arrhythmogenesis. These drugs, their targets, and their potential ability to improve and disrupt current care paradigms will be reviewed in this session.

Kristen Bova Campbell

Clinical Pharmacy Specialist and Senior Research Associate in Electrophysiology

Duke University Medical Center

Mina K. Chung

Staff Cardiologist & Professor of Medicine in the Section of Pacing and Electrophysiology

Cleveland Clinic

Shilpi Epstein

Global Clinical Lead, Cardiovascular Clinical Development

Bayer

Dan Musat

Cardiac Electrophysiologist

Valley Health System

Rod Passman

Jules Reingold Professor of Electrophysiology & Cardiac Electrophysiologist

Northwestern University Feinberg School of Medicine

Steven Lubitz

Director of Translational Medicine

Novartis

September 06, 2025

2025-09-06

08:45 AM (EDT) - 09:30 AM (EDT)

Main Stage 2

Concurrent Session

Wearables and the Future

The advent of multiple sensors in wearables begins to provide clinicians with a treasure trove of data of unknown impact and usefulness. This session will examine tech and the patient experience of employing it.

Ricky Bloomfield

Chief Medical Officer

ŌURA

Derek Exner

Chief Medical Officer

HelpWear Inc.

Srinivasan Murali

CEO & Co-Founder

SmartCardia

Uma Srivatsa

Senior Cardiac Electrophysiologist | Professor and Director of Arrhythmia Services

University of California - Davis

Mintu Turakhia

Chief Medical and Scientific Officer + EVP, Product Management and Innovation | Professor of Medicine and Cardiac Electrophysiologist

iRhythm Technologies, Inc. | Stanford University

Jagmeet Singh

Professor of Medicine | Cardiac Electrophysiologist & Founding Director of the Resynchronization and Advanced Cardiac Therapeutics Program

Harvard Medical School | Massachusetts General Hospital Heart Center

September 05, 2025

2025-09-05

02:00 PM (EDT) - 02:45 PM (EDT)

Main Stage 2

Concurrent Session

Development of Autonomous Mapping Systems

Self-driving cars, remote control of drones, and self-navigating planes are all current realities. However, mapping and ablation of cardiac arrhythmias is a completely human and labor-intensive endeavor, despite many advances over the years. This session will discuss the key barriers and potential solutions that may enable remote control of mapping and ablation as well as semi-autonomous systems for mapping and ablation.

Isabel Deisenhofer, MD

Head, Department of Electrophysiology

German Heart Center Munich Department of Electrophysiology

Sabine Ernst

Professor of Practice (Cardiology)

Imperial College London

Mitchell Faddis

Director of the Cardiac EP Section

Washington University

Shlomo Shpun

Chief Scientific Office

TechWald Holding S.p.A.

Jennifer N. Avari Silva

Co-Founder & CMO | Associate Professor & Director of Pediatric Electrophysiology

SentiAR, Inc. | Washington University in St. Louis

Sanjiv Narayan

Professor of Medicine | Director of the NIH T32 Computational Medicine Training Program (CHIP) | Co-Director of the Arrhythmia Center

Stanford University

2025-09-05

12:30 PM (EDT) - 01:15 PM (EDT)

Main Stage 1

Concurrent Session

Heart Rhythm Innovation Morbidity and Mortality Conference – Avoiding Fatal Pitfalls

Not all innovation is successful. Many potential innovations fail in the pre-clinical or early testing phases – often for common reasons. This session will discuss the potential pitfalls in device development and how innovators can navigate these challenges with greater confidence by avoiding mistakes and missteps. The panel will discuss their “dream” innovations that didn’t come to fruition – and what they learned.

Daniel Cantillon

Adult EP Cardiologist & Chief Medical Officer

Masimo Corporation

Howard R. Levin

CEO & Chief Medical Officer

Deerfield Catalyst

Jennifer N. Avari Silva

Co-Founder & CMO | Associate Professor & Director of Pediatric Electrophysiology

SentiAR, Inc. | Washington University in St. Louis

Mintu Turakhia

Chief Medical and Scientific Officer + EVP, Product Management and Innovation | Professor of Medicine and Cardiac Electrophysiologist

iRhythm Technologies, Inc. | Stanford University

Alicia C. Rodriguez

Founder & CEO

Bloomer Tech

Avi Fischer, MD, FHRS

Senior Vice President, Medical Affairs and Innovation

Orchestra BioMed, Inc.

September 04, 2025

2025-09-04

02:00 PM (EDT) - 02:45 PM (EDT)

Main Stage 1

Concurrent Session

Remote Monitoring and Data Management: Challenges and Innovations

In this session, we will delve into the evolving landscape of remote monitoring, addressing the increasing challenges associated with managing vast amounts of data collected from wearables, implantables, and external monitoring devices. We will explore the complexities of integrating data across diverse platforms, with a particular focus on overcoming interoperability barriers.

Jessica Mullenix

Cardiac Electrophysiology Nurse Practitioner

U.S. Department of Veterans Affairs Cardiology Office

Carissa Pistilli

Advanced Nurse Practitioner

Valley Health System

Yekaterina Spivak

Physician Assistant | Inventor & Founder

Children's Hospital of Philadelphia | Laally

Julie Thomas

Electrophysiology Physician Assistant & EP Supervisor

North Shore University Hospital

Amy Tucker

Nurse Manager of the Cardiac Device Clinic

Sanger Heart & Vascular Institute (SHVI)

Rebecca Yapejian

CRM Senior Field Clinical Representative | Cardiac Electrophysiology Nurse Practitioner | Former Software Engineer

Boston Scientific | DOCS Health Careers

Aileen Ferrick

Assistant Director of Cardiac Electrophysiology Research | Acute Care Nurse Practitioner

White Plains Hospital

September 05, 2025

2025-09-05

04:45 PM (EDT) - 05:30 PM (EDT)

Main Stage 2

Concurrent Session

Cutting-Edge Ablation Techniques That Challenge Traditional Methods And Improve Patient Outcomes

Jennifer N. Avari Silva | Daniel Cooper | Sabine Ernst | J. Peter Weiss | Paul Zei

What’s next in the evolution of cardiac ablation technology? This session explores whether ease of use will translate into superior outcomes, the potential of novel energy sources, and the role of robotics, AR, and VR in procedural automation. Experts will also discuss the promise of computational modeling in personalizing ablation strategies—are we truly on the brink of precision ablation, or is clinical translation still a work in progress?

Daniel Cooper

Professor of Medicine | Director of the Clinical Cardiac Electrophysiology Fellowship

Washington University School of Medicine

Sabine Ernst

Professor of Practice (Cardiology)

Imperial College London

Devi G Nair, MD, FACC, FHRS

Director of the Cardiac Electrophysiology & Research

St. Bernards Medical Center & Arrhythmia Research Group

J. Peter Weiss

Cardiac Electrophysiologist

Banner University of Arizona Medical Center Phoenix (BUMCP)

Paul Zei

Cardiac Electrophysiologist

Brigham and Women’s Hospital

Jennifer N. Avari Silva

Co-Founder & CMO | Associate Professor & Director of Pediatric Electrophysiology

SentiAR, Inc. | Washington University in St. Louis

2025-09-05

10:30 AM (EDT) - 11:15 AM (EDT)

Main Stage 2

Concurrent Session

The Permanent Pacing of Tomorrow

Mikhael El-Chami | Neal Bhatia | Janet K. Han | Anne Kroman | Kathryn Hilpisch

This session will detail the possibilities, potential technologies, and likely pathways for permanent pacing in the future. Specifically, this session will explore next generation pacing technologies, including but not limited to advances in leadless pacing, micro-devices, new epicardial pacing interventions, pacing for HFpE, and physiologic atrial pacing.

Neal Bhatia

Cardiac Electrophysiologist | Co-Director of the Complex Ventricular Tachycardia Ablation Program

Emory University Hospital System

Janet K. Han

Associate Professor of Medicine | Cardiac Electrophysiology

UCLA | VA Greater Los Angeles Healthcare System / UCLA | Digital Health & Virtual Care

Anne Kroman

Associate Professor of Cardiac Electrophysiology | Director of the Lead Management Program, the Cardiac Device Clinic, and MUSC Heart Station

Medical University of South Carolina

Kathryn Hilpisch

Distinguished Scientist

Medtronic

Mikhael El-Chami

Electrophysiologist | Professor of Medicine

Emory University

2025-09-05

09:45 AM (EDT) - 10:30 AM (EDT)

Main Stage 2

Concurrent Session

Innovations in Autonomic Therapies for Atrial Fibrillation

Jonathan Piccini | Marat Fudim | Sanjiv Narayan | Stavros Stavrakis | Kalyanam Shivkumar

The autonomic nervous system is known to play a critical role in the initiation and/or triggering of many arrhythmias, including atrial fibrillation. Autonomic therapies have moved well-beyond isolated ablation of cardiac ganglionated plexi. This session will review the innovations that have expanded autonomic therapies, including tragus stimulation, renal sympathetic denervation, and future innovations for additional interventions.

Marat Fudim

Associate Professor & Heart Failure Cardiologist

Duke University Medical Center

Sanjiv Narayan

Professor of Medicine | Director of the NIH T32 Computational Medicine Training Program (CHIP) | Co-Director of the Arrhythmia Center

Stanford University

Stavros Stavrakis

Clinical Electrophysiologist | Associate Professor

Kalyanam Shivkumar

Professor & Director, Center for Interventional Programs

UCLA Health System, UCLA Cardiac Arrhythmia Center & EP Programs

Jonathan Piccini

Cardiac Electrophysiologist & Professor of Medicine and Population Health | Director of the Cardiac Electrophysiology section

Duke University Hospital and the Duke Clinical Research Institute | Duke Heart Center

September 04, 2025

2025-09-04

04:30 PM (EDT) - 05:15 PM (EDT)

Main Stage 1

Concurrent Session

Evolution, Integration, and Disruption of Ultrasound Technologies in the EP Laboratory

There is an unprecedented surge in innovation surrounding intracardiac ultrasound and its integration into electrophysiologic care. Future iterations of 4-D intracardiac ultrasound, next-generation integration into mapping systems, and the use of ultrasound for therapeutic purposes all have the potential to significantly change practice. This session will review these key innovations and how they may improve care in the EP laboratory.

Luigi Di Biase, MD, PhD, FHRS

Clinical Cardiac Electrophysiology

Albert Einstein College of Medicine at Montefiore Health System

Kenneth Ellenbogen

Director of Clinical Cardiac Electrophysiology and Pacing | Kimmerling Chair of Cardiology | President

Virginia Commonwealth University | Heart Rhythm Society

Christoph Hennersperger

Co-Founder & Chief Technology Officer

LUMA Vision

Stephen Metz

Head of Artificial Intelligence and Ultrasound Adv. Applications

Siemens Healthineers

Binh C. Tran

Senior R&D Fellow

Boston Scientific

Roy Urman

Senior R&D Manager

Johnson & Johnson MedTech Electrophysiology

Amin Al-Ahmad

Cardiac Electrophysiologist

Texas Cardiac Arrhythmia

2025-09-04

03:45 PM (EDT) - 04:30 PM (EDT)

Innovation Stage

Concurrent Session

Personalized Care Through Digital Twins – Foundational or Fantasy?

Natalia Trayanova | Patrick Boyle | Jonathan Chrispin | Tanmay Gokhale | Liat Tsoref

Digital twins offer the promise to develop, test, and validate potential personalized solutions for heart rhythm care that are unique to a given individual and their myocardial substrate. Early studies have been promising. However, there are significant challenges from several different areas including operational, computational, and efficacy. This session will engage in discussing whether digital twins will become a foundational core of EP care or remain a fantasy.